Prevnar 13 FDA Approval History
FDA Approved: Yes (First approved February 24, 2010)
Brand name: Prevnar 13
Generic name: pneumococcal 13-valent conjugate vaccine
Company: Pfizer Inc.
Treatment for: Pneumococcal Disease Prophylaxis
Prevnar 13 (pneumococcal 13-valent conjugate vaccine) is a vaccine indicated for active immunization against invasive pneumococcal disease.
Development timeline for Prevnar 13
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.